Global Health Watch 1 in one file
Global Health Watch 1 in one file Global Health Watch 1 in one file
Holding to account | E7 poorest parts of the world, and reflect a Northern look at Southern problems, proposing global solutions without sufficiently acknowledging the diversity of nations or local factors. To counter this, a stronger emphasis is needed on capacity development for ‘horizontal’ health research, so as to increase the capacity of a country to deal with its own priority health problems and to negotiate the balance between local and global priorities. Implicit in this is the need for greater efforts to improve South-South and South-North partnerships and a commitment to fund and strengthen the voice and capacity of the South. Other issues that may counter any progress are the enormous growth in private sector health research in the South, mostly from pharmaceutical companies, and the effects of intellectual property rights and trade laws on health and health research (see the more detailed discussion in chapter B2). Neither the Bangkok Conference nor the Mexico Summit adequately addressed these issues, even though the pharmaceutical industry is now the single largest contributor to health research funds in the South – by 2000, its investments were worth over US$ 3 billion. To the best of our knowledge, there has been no concise assessment of the impact on this shift in research funding on research infrastructure, training, ethics, equity and development: it is urgently required. On a more positive note, it has been increasingly recognized over the past two decades that a strong civil society is a cornerstone of democracy, progress and health (Edelman 2005), not least because of its watchdog function. The role of civil society in health research was recognized at the 2004 Mexico Summit, but was not acknowledged in the final Ministerial statement. Regular review of progress with international declarations, statements, financing, practice and other efforts will be key to the advocacy needed to make health research beneficial for everyone. This chapter has aimed to outline positive and negative trends in health research in recent years. It concludes with some suggested indicators to measure progress in future: • national health research systems – progress towards impact and self-sufficiency. • partnerships for health research – progress toward equitable partnerships, and their impact on national health priorities. • health research funding – progress towards strengthening local research capacity and addressing national health research priorities. • effects of health research funded by the private sector – understanding its benefits and harms, globally and nationally. 348
• global architecture for health research governance – progress towards better but equitable coordination. • knowledge management and sharing – progress towards increased access to and utilization of knowledge from North to South and South to North. • health systems research – progress towards developing methodologies, building capacity, and implementing research on health system performance. • effects of health research related to MDGs – understanding of potentials and limitations, globally and nationally. • impact on health – documenting and measuring the impact of health research (from any source) on health, health equity and development in the poorest countries. References Certain, E (2004). FAME: an initiative to promote local medical research publishing in Africa. Saudi Medical Journal, 25, S46. Chandiwana S, Ornberg N (2003). Review of North-South and South-South Cooperation and Conditions Necessary to Sustain Research Capability in Developing Countries. Journal of Health, Population and Nutrition, 21, 288–297. Commission on Health Research for Development (COHRED) (1990). Health research essential link to equity in development. Oxford, Oxford University Press. COHRED (2004). Health Research expenditures: essential information for rational decision-making (2004.2). Making Health Research Work for Everyone. Geneva, Council on Health Research for Development. Deangelis C et al. (2004). Registration of clinical trials: a statement from the International Committee of Medical Journal Editors. Ned Tijdschr Geneeskd, 148, 1870–1. Dickersin K, Rennie D (2003). Registering Clinical Trials. JAMA, 290, 516–523. Dwyer O (2004). WHO to unveil global clinical trials register. Bulletin of the World Health Organization, 82, 714. Edelman (2005). Sixth Annual Edelman Trust Barometer: A global study of opinion leaders (http://www.edelman.com/image/insights/content/Edelman_Trust_ Barometer-2005_final_final.pdf, accessed 14 March 2005). Farley S (2005). Support to Science, Technology, and Knowledge for Development: A snapshot of the Global Landscape. The Africa-Canada-UK Exploration: Building Science and Technology capacity with African Partners. London. Global Forum for Health Research (2004). Monitoring Financial Flows for Health Research. Geneva, Global Forum for Health Research. Horton R (2003). Medical journals: evidence of bias against the diseases of poverty. Lancet, 361, 712–3. Ijesselmuiden C, Duale S, Nchinda T (2004). Principles of Good Partnerships for Strengthening Public Health Education Capacity in Africa. Report of a Consultative Meeting, Geneva, Council on Health Research for Development. Keiser J et al. (2004). Representation of authors and editors from countries with different human development indexes in the leading literature on tropical medicine: survey of current evidence. BMJ, 328, 1229–32. Essential health research 349
- Page 315 and 316: prompted a global debate on how to
- Page 317 and 318: E3 | The World Bank and the Interna
- Page 319 and 320: 22 World Bank: the centre of world
- Page 321 and 322: approach to conditionality is being
- Page 323 and 324: tal policies should explicitly refe
- Page 325 and 326: E4 | Big business This chapter deal
- Page 327 and 328: 23 The Marlboro Man was described b
- Page 329 and 330: dedicated funding [Articles 5.6 and
- Page 331 and 332: grass roots in building government
- Page 333 and 334: 24 A pack of Cerelac cereal food pu
- Page 335 and 336: USAID has also funded work on breas
- Page 337 and 338: (from whatever its source, and howe
- Page 339 and 340: These trends in taxation are underp
- Page 341 and 342: Norway Denmark Netherlands Luxembou
- Page 343 and 344: Global aid trends - allocation Wher
- Page 345 and 346: weapons, vehicles and military trai
- Page 347 and 348: table e5.1 Value (in £) of new DFI
- Page 349 and 350: OECD (2005). Development Co-operati
- Page 351 and 352: 25 Breaking the chains of debt: pro
- Page 353 and 354: Box E6.1 Zambia: inflation or death
- Page 355 and 356: have met the Fund’s conditions, a
- Page 357 and 358: E7 | Essential health research Rese
- Page 359 and 360: Developing national health research
- Page 361 and 362: for African Medical Editors (Certai
- Page 363 and 364: Neither the consultations leading u
- Page 365: Box E7.4 Asking the social-politica
- Page 369 and 370: part f | Conclusions Global Health
- Page 371 and 372: current debt relief mechanism - the
- Page 373 and 374: agreement, and taking health and he
- Page 375 and 376: ity of the now-developed countries
- Page 377 and 378: tion and water are experiencing sim
Hold<strong>in</strong>g to account | E7<br />
poorest parts of the world, and reflect a Northern look at Southern problems,<br />
propos<strong>in</strong>g global solutions without sufficiently acknowledg<strong>in</strong>g the diversity<br />
of nations or local factors. To counter this, a stronger emphasis is needed on<br />
capacity development for ‘horizontal’ health research, so as to <strong>in</strong>crease the capacity<br />
of a country to deal with its own priority health problems and to negotiate<br />
the balance between local and global priorities. Implicit <strong>in</strong> this is the need for<br />
greater efforts to improve South-South and South-North partnerships and a<br />
commitment to fund and strengthen the voice and capacity of the South.<br />
Other issues that may counter any progress are the enormous growth <strong>in</strong><br />
private sector health research <strong>in</strong> the South, mostly from pharmaceutical companies,<br />
and the effects of <strong>in</strong>tellectual property rights and trade laws on health<br />
and health research (see the more detailed discussion <strong>in</strong> chapter B2). Neither<br />
the Bangkok Conference nor the Mexico Summit adequately addressed these<br />
issues, even though the pharmaceutical <strong>in</strong>dustry is now the s<strong>in</strong>gle largest<br />
contributor to health research funds <strong>in</strong> the South – by 2000, its <strong>in</strong>vestments<br />
were worth over US$ 3 billion. To the best of our knowledge, there has been<br />
no concise assessment of the impact on this shift <strong>in</strong> research fund<strong>in</strong>g on research<br />
<strong>in</strong>frastructure, tra<strong>in</strong><strong>in</strong>g, ethics, equity and development: it is urgently<br />
required.<br />
On a more positive note, it has been <strong>in</strong>creas<strong>in</strong>gly recognized over the past<br />
two decades that a strong civil society is a cornerst<strong>one</strong> of democracy, progress<br />
and health (Edelman 2005), not least because of its watchdog function. The<br />
role of civil society <strong>in</strong> health research was recognized at the 2004 Mexico Summit,<br />
but was not acknowledged <strong>in</strong> the f<strong>in</strong>al M<strong>in</strong>isterial statement. Regular<br />
review of progress with <strong>in</strong>ternational declarations, statements, f<strong>in</strong>anc<strong>in</strong>g,<br />
practice and other efforts will be key to the advocacy needed to make health<br />
research beneficial for every<strong>one</strong>.<br />
This chapter has aimed to outl<strong>in</strong>e positive and negative trends <strong>in</strong> health<br />
research <strong>in</strong> recent years. It concludes with some suggested <strong>in</strong>dicators to measure<br />
progress <strong>in</strong> future:<br />
• national health research systems – progress towards impact and self-sufficiency.<br />
• partnerships for health research – progress toward equitable partnerships,<br />
and their impact on national health priorities.<br />
• health research fund<strong>in</strong>g – progress towards strengthen<strong>in</strong>g local research<br />
capacity and address<strong>in</strong>g national health research priorities.<br />
• effects of health research funded by the private sector – understand<strong>in</strong>g its<br />
benefits and harms, globally and nationally.<br />
348